Newtyn Management, LLC Wave Life Sciences Ltd. Transaction History
Newtyn Management, LLC
- $458 Million
- Q2 2024
A detailed history of Newtyn Management, LLC transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Newtyn Management, LLC holds 475,000 shares of WVE stock, worth $2.44 Million. This represents 0.52% of its overall portfolio holdings.
Number of Shares
475,000
Previous 500,000
5.0%
Holding current value
$2.44 Million
Previous $3.09 Million
23.18%
% of portfolio
0.52%
Previous 0.67%
Shares
7 transactions
Others Institutions Holding WVE
# of Institutions
146Shares Held
93.1MCall Options Held
33KPut Options Held
57.2K-
Ra Capital Management, L.P. Boston, MA18.2MShares$93.4 Million1.37% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx7.67MShares$39.3 Million0.75% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$34.6 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$31.6 Million35.47% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.36MShares$27.5 Million0.05% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $445M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...